2024-11-28 11:53:27
Ascletis Announces IND Filing of Oral RdRp Inhibitor ASC10 for COVID-19 Accepted by China NMPA
Corporate/ 2023-07-24
Ascletis Announces IND Filing of Oral Rd...

HANGZHOU,China and SHAOXING,China,Aug. 4,2022--Ascletis Pharma Inc. (HKEX: 1672,"Ascletis") today announces that the Investigation...

The Debut of TIANGEN Received Passionate Feedback at AACC 2022
Health/ 2023-07-22
The Debut of TIANGEN Received Passionate...

CHICAGO,Aug. 4,2022-- TIANGEN,a high-tech biological enterprise,demonstrated its groundbreaking nucleic acid extraction solution and custome...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release